http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2182492-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86de7d9f2e6454d7c2f6aeaf3b9541b6
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
filingDate 2000-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eb05db3345482715f6c1ebd11f35d30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23f27ff982acb398c62ba142b866aa7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63fb7196b7dd5b70cdeeb5c3effb9a5d
publicationDate 2002-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2182492-C1
titleOfInvention Medicinal preparation to treat narcotic dependence
abstract FIELD: medicine, pharmacology. SUBSTANCE: preparation to treat narcotic dependence is represented as antilogarithmic form of antibodies to morphine or morphine to hydrochloride obtained due to subsequent multiple dilution and external impact, predominantly, containing the mixture of homeopathic dilutions A30 and/or A200. Preparation could be used for treatment and secondary prophylaxis of narcotic dependence, mainly, an opium abstinential syndrome and, also, to decrease patient's inclination to narcotic preparations of different groups, treat psychosomatic disorders as a result of intake of different narcotic preparations, treat abstinential syndrome and affect altered tolerance due to regular intake of narcotic preparations. EFFECT: higher efficiency. 5 cl, 6 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2703494-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9522116-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-202014101773-U1
priorityDate 2000-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID622766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415858398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453865105
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507808
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416043528
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3469
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6V115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859022
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE2RVI8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19104
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6148
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491494
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO73860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5464110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462328

Total number of triples: 37.